MDNews - Lower Hudson/Bronx

February 2016

Issue link: https://viewer.e-digitaledition.com/i/635241

Contents of this Issue

Navigation

Page 28 of 31

LOCAL NEWS NewYork-Presbyterian/ Hudson Valley Hospital has been recognized as par t of The Joint Commission's 2015 annual repor t America's Hospitals: Improving Quality and Safety for attaining and sustaining excellence in accountability measure per formance for hear t attack, hear t failure, pneumonia, surgical care, venous thromboembolism and stroke. The Top Performer pro - gram recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions. This is the second year NYP/Hudson Valley has been recognized as a Top Performer. NYP/Hudson Valley was recognized in 2014 for its performance on accountability measure data for heart attack, heart failure, pneumonia and surgical care in 2013. For more information about the Top Performer program, visit jointcommission.org/accreditation/top_performers.aspx. The Center for Sleep Medicine at NewYork-Presbyterian/Lawrence Hospital in Bronxville recently received program accreditation from the American Academy of Sleep Medicine (AASM). To receive ac - creditation for a five-year period, a sleep center must meet or exceed all standards for professional health care as designated by the AASM. These standards address core areas such as personnel, facility and equipment, policies and procedures, data acquisition, patient care, and quality assurance. Additionally, the sleep center's goals must be clearly stated and include plans for positively affecting the quality of medical care in the community it serves. The Center for Sleep Medicine at NewYork-Presbyterian/Lawrence Hospital, located on the fifth floor of the hospital at 55 Palmer Ave., is a state-of-the-art facility that provides diagnostic and treatment services for all types of sleep disorders. Patients undergo testing in the comfort of private, hotel-style suites and are attended to by the top clinical specialists. Its medical director, Deborah Cappell, MD, is a board-certified sleep specialist who can see patients in consulta - tion before or after a sleep study. To learn more about the treatment of sleep disorders or to schedule a consultation or sleep study, visit nyplawrence.org. Phelps Memorial Hospital Center has achieved "Exemplar" status — the highest of all possible program levels — for its NICHE (Nurses Improving Care for Healthsystem Elders) program. Phelps is one of only 10 hospitals in New York State to have achieved this status. NICHE, based at NYU College of Nursing, is designed to help nurses provide specialized care to patients age 65 and older. "Exemplar" status recognizes Phelps' ongoing, high-level dedica - tion to providing the highest quality, most appropriate care to older adults. The status was attained following a rigorous evaluation of the hospital's current NICHE program and its future goals for the pro- gram. The requirements include implementing the NICHE Geriatric Resource Nurse (GRN) model and evidence-based protocols on all applicable hospital units; applying aging-sensitive policies; incorpo- rating input from patients, families and other healthcare providers in the development and execution of NICHE initiatives; and assuming regional and national leadership roles. Investigators at the Children's Hospital of Montefiore have re - ceived a four-year, $1.6 million grant from the U.S. Food and Drug Administration to evaluate the effectiveness and safety of a specific form of intravenous immune globulin (IVIG), a biologic medicine that may significantly reduce pain and hospitalizations for children and young adults (ages 8 to 21 years) with sickle cell disease (SCD). Opioid therapy is the standard treatment for children and young adults managing acute pain caused by SCD due to associated blood vessel blockages. However, studies conducted at Montefiore Health System and Albert Einstein College of Medicine suggest IVIG could be a prom - ising new treatment. If positive, the outcome of this Phase 2 research will be an appropriately powered Phase 3 study, a crucial step toward development of a novel therapy for SCD-related vaso-occlusive cri - ses"(VOC), the medical term for the blood vessel blockages associated with the acute pain of SCD. A. Bonnie Corbett, Chief Nursing Officer and Vice President of Patient Care Services, and John C. Federspiel, President, hold the certificate recognizing NewYork-Presbyterian/ Hudson Valley Hospital as a 2014 Top Performer on Key Quality Measures. L O C A L N E W S ❰❰❰❰❰ 2 9 M D N E W S . C O M /// M D N E W S L O W E R H U D S O N / B R O N X ■ 2 016 2 9

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - February 2016